SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM
SQZ Biotechnologies Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 10.19M | 24.71M | 39.87M | 63.71M | 84.24M | 105.56M | 122.91M | 143.51M | 164.25M | 185.07M | 204.93M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 2.31M | 2.31M | 2.31M | 2.31M | 2.61M | 2.62M | 2.63M | 2.63M | 2.31M | 2.31M | 2.31M |
Receivables | n/a | n/a | n/a | 384K | n/a | n/a | n/a | 3M | n/a | 52K | 28K |
Inventory | n/a | n/a | n/a | -384K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 1.89M | 2.98M | 4.58M | 4.5M | 3.1M | 4.49M | 5M | 4.12M | 1.91M | 4.14M | 6.16M |
Total Current Assets | 12.09M | 27.68M | 44.45M | 68.2M | 87.34M | 110.05M | 127.92M | 150.63M | 166.17M | 189.26M | 211.11M |
Property-Plant & Equipment | 15.4M | 24.16M | 26.4M | 29.39M | 64.91M | 67.64M | 70.25M | 72.89M | 75.6M | 46.99M | 49.45M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 17.7M | 26.46M | 28.71M | 31.7M | 67.52M | 70.26M | 72.88M | 75.52M | 77.91M | 49.29M | 51.76M |
Total Assets | 29.79M | 54.15M | 73.16M | 99.9M | 154.85M | 180.31M | 200.8M | 226.15M | 244.07M | 238.55M | 262.87M |
Account Payables | 1.91M | 1.56M | 2.48M | 2.51M | 3.31M | 1.66M | 1.2M | 3.97M | 2.39M | 2.1M | 3.95M |
Deferred Revenue | n/a | 500K | 678K | 715K | 3.5M | 6.63M | 9.64M | 12.51M | 21.86M | 26.61M | 25.52M |
Short-Term Debt | 2.4M | 2.66M | 4.19M | 6.56M | 10.63M | 10.45M | 10.13M | 9.94M | 9.2M | 9.88M | 8.37M |
Other Current Liabilities | 4.52M | 5.19M | 5.34M | 12.05M | 7.82M | 9.71M | 8.53M | 6.81M | 5.66M | 5.25M | 4.54M |
Total Current Liabilities | 8.83M | 9.91M | 12.69M | 21.84M | 25.26M | 28.44M | 29.5M | 33.22M | 39.11M | 43.84M | 42.38M |
Long-Term Debt | 19.07M | 19.7M | 20.31M | 20.91M | 51.82M | 54.48M | 57.19M | 59.76M | 62.36M | 32.61M | 36.4M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 205K | 205K | 205K |
Total Long-Term Liabilities | 19.07M | 19.7M | 20.31M | 20.91M | 61.02M | 63.68M | 66.38M | 68.95M | 71.76M | 42.02M | 51.21M |
Total Liabilities | 27.91M | 29.61M | 33M | 42.75M | 86.28M | 92.12M | 95.88M | 102.18M | 110.87M | 85.85M | 93.59M |
Total Debt | 21.47M | 22.36M | 24.5M | 27.47M | 62.45M | 64.93M | 67.32M | 69.69M | 71.56M | 42.49M | 44.77M |
Common Stock | 29K | 29K | 29K | 29K | 29K | 29K | 28K | 28K | 28K | 28K | 28K |
Retained Earnings | -333.07M | -309.43M | -292.66M | -274.97M | -261.43M | -238.78M | -216.55M | -195.51M | -183.69M | -161.24M | -142.17M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.09M | -3.86M |
Shareholders Equity | 1.88M | 24.54M | 40.16M | 57.15M | 68.57M | 88.19M | 104.91M | 123.98M | 133.21M | 152.7M | 169.28M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |